Cerebral Infarction: Clinical Trials

1 trial for Cerebral Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1
Phase 31Withdrawn 1

Follow Cerebral Infarction: new trials by email Literature Review of Cerebral Infarction trials Research Report on Cerebral Infarction

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
Tenecteplase, Alteplase - Ischemic Stroke
Phase 2 / Phase 3WithdrawnReza Behrouz, DO2015-01-012015-09-23

Narrower conditions

Ischemic Stroke (1)

Broader conditions

Brain Diseases (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Necrosis (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Stroke (1)  ·  Vascular Diseases (1)

Interventions

Tenecteplase (1)  ·  Tissue Plasminogen Activator (1)

Sponsors

Reza Behrouz, DO (1)

Countries

United States (1)

Top investigators

Reza Behrouz, DO (1)

Results publications

PMID 26387127